Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes / By Roots Analysis

According to the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, biopharmaceutical manufacturers have been reported to outsource more than 30% of their fill / finish operations to contract service providers. Owing to the benefits, such as inherent safety and ease-of-use, and provisions to reduce dosing errors, risk of occlusions, extravasation and phlebitis, several injectable drugs (Humira®, Enbrel®, Avastin®, PREVNAR 13®, ALPROLIX® and Benefix®), diluents and other products requiring parenteral administration, are packaged in prefilled syringes.

 

Key Inclusions

• A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes, along with analyses based on a number of relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of the headquarters, location of fill / finish facilities, type of drug molecule (small molecule and biologic), syringe barrel material (glass and plastic), syringe fill volume and additional services offered (drug formulation, regulatory support, labelling and packaging, terminal sterilization, storage and logistics). In addition, the chapter includes details on prefilled syringe fill / finish installed capacity of the service providers.   
• Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific. Each profile provides an overview of the company, information on its overall service portfolio, fill / finish facilities, financial performance (if available), and details on recent developments as well as an informed future outlook.
• An analysis of the recent developments (since 2015) pertaining to contract fill / finish services, based on various parameters, such as year of development, type of activity / development (collaboration and expansions), scale of operation of the project, location of expanded facility, type of drug molecule involved and additional services offered.
• An estimate of the global, contract fill / finish capacity of prefilled syringes, by taking into consideration the capacities of various fill / finish service providers (as available on respective company websites), collected via secondary and primary research. The study examines the distribution of number of prefilled syringe units and volume of drug filled, based on the company size of manufacturer (small-sized, mid-sized and large), scale of operation (preclinical / clinical and commercial), location of headquarters and fill / finish facilities (North America, Europe and Asia-Pacific) and type of drug molecule (small molecule and biologics).
• An informed estimate of the annual demand for fill / finish of prefilled syringes (in number of units), taking into account the marketed drugs available in prefilled syringes and other relevant parameters, such as target patient population, dosing frequency and dose strength. The study provides the distribution of the annual demand, based on the geography (North America (US), Europe (UK, France, Italy, Spain, Germany and rest of Europe), Latin America (Brazil, Mexico, Argentina and rest of Latin America), Asia-Pacific (Japan, China, India, South Korea and rest of Asia-Pacific), and the Middle East and Africa (Saudi Arabia, UAE, Africa and rest of the Middle East)), type of drug molecule (small molecule and biologics), therapeutic area (blood disorders, infectious diseases, metabolic disorders, oncological disorders and others), syringe barrel material (glass and plastic) and number of barrel chambers (single chamber and dual chamber).

 

To order this 260+ page report, which features 60+ figures and 110+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

 

The USD 3 billion (by 2030) financial opportunity within the prefilled syringe fill / finish services market has been analyzed across the following segments:

• Scale of Operation

• Preclinical / Clinical
• Commercial

 

• Type of drug molecule

• Biologic
• Small Molecule

 

• Target therapeutic area
• Blood disorders
• Infectious diseases
• Metabolic disorders
• Oncological disorders
• Neurological disorders
• Autoimmune disorders
• Others

 

• Syringe barrel material

• Glass
• Plastic

 

• Number of barrel chambers

• Single chamber
• Dual chamber

 

• Key geographical regions
• North America
• Europe
• Latin America
• Asia Pacific
• Middle East and Africa

 

Table of Contents

 

1.         Preface

2.         Executive Summary

 

3.         Introduction

 

4.         Market Landscape

 

5.         Prefilled Syringe Fill / Finish Service Providers in North America: Company Profiles

 

6.         Prefilled Syringe Fill / Finish Service Providers in Europe: Company Profiles

 

7.         Prefilled Syringe Fill / Finish Service Providers in Asia-Pacific: Company Profiles

 

8.         Prefilled Syringe Fill / Finish Service Providers: Recent Developments

 

9.         Capacity Analysis

 

10.        Demand Analysis

 

11.        Geographical Assessment of Demand and Supply

 

12.        Likely Partner Analysis

 

13.        Market Sizing and Opportunity Analysis

 

14.        Future Growth Opportunities

 

15.        Case Study: Prefilled Syringe Manufacturers

 

16.        Concluding Remarks

 

17.        Interview Transcripts

 

18.        Appendix 1: Tabulated Data

 

19.        Appendix 2: List of Companies

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]